miR-15b targets Igf1r to potentially inhibit mammary cancer cell proliferation. Studies using mouse models suggest that reduction of bioavailable IGF1 mediates many anticancer effects of CR [52,53,54,55]. Here, IGF1R is linked to breast cancer.